Pramipexole Dihydrochloride 2.25 mg/1

Pramipexole Dihydrochloride 2.25 mg/1 is an extended-release tablet used for managing symptoms of Parkinson's disease and restless legs syndrome. This medication helps regulate dopamine levels in the brain, promoting smoother movement and reducing discomfort.

Pramipexole Dihydrochloride is primarily used to treat symptoms associated with Parkinson's disease, such as tremors, stiffness, and poor muscle control. It is also prescribed for restless legs syndrome, helping to alleviate the urge to move the legs due to uncomfortable sensations. The extended-release formulation ensures a steady release of the medication over time, providing consistent relief throughout the day.

Common effects of Pramipexole Dihydrochloride may include dizziness, nausea, and fatigue. Some users might experience insomnia or vivid dreams. These effects vary among individuals and typically diminish as the body adjusts to the medication.

Pramipexole Dihydrochloride should be handled with care, especially for those with a history of low blood pressure, heart conditions, or psychiatric disorders. It is important to follow the prescribed dosage and consult a healthcare provider before making any changes. Avoid sudden discontinuation without medical advice.

Pramipexole Dihydrochloride may interact with alcohol, increasing the risk of dizziness and drowsiness. It can also interact with certain medications that affect dopamine levels or are metabolized by the liver's CYP enzymes. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.